Skip to main content
Clinical Trials/CTRI/2022/10/046903
CTRI/2022/10/046903
Not Yet Recruiting
Phase 3

In vivo and Clinical Study To Evaluate The Efficacy Of Katakakhadiradi Ghana Vati Tiktaka Ghrita Tarpan In Pramehajanya Timira With Special Reference To Non Proliferative Diabetic Retinopathy A Randomized Controlled Trial

ational Institute of Ayurveda Jaipur0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: H36- Retinal disorders in diseases classified elsewhere
Sponsor
ational Institute of Ayurveda Jaipur
Status
Not Yet Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
ational Institute of Ayurveda Jaipur

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients in the age group of 20 to 70 years
  • 2\.Known cases of Type I and Type II diabetes mellitus with 5years of history
  • 3\.Patients with well controlled blood sugar level
  • 4\.Patients with visual symptoms like blurring of vision, floaters etc
  • 5\.Patients with mild to moderate NPDR
  • 6\.Patients willing to give written consent

Exclusion Criteria

  • 1\.Patients with severe NPDR or with PDR, Diabetic Maculopathy.
  • 2\.Patients with Diabetic Retinopathy with complications like Retinal detachment, posterior vitreal detachment, acute vitrealhemorrhage, Rubiosis Iridis.
  • 3\.Gestational Diabetic Retinopathy.
  • 4\.Severe visual impairments like high Myopia, Retinitis Pigmentosa, Mature Cataract, post Cataract surgeries, Glaucoma.
  • 5\.Patients with other systemic complaints like Hypertension, Renal impairment, COPD, cardiovascular diseases.

Outcomes

Primary Outcomes

Not specified

Similar Trials